12,222 followers
@CircIntv Congrats @TsuyoshiKaneko1 @PinakShahMD @AdamGreenbaumMD @bapat_savrtavr @tavrkapadia et al on +ve S3 AVIV 1y outcomes vs de novo #TAVR in TVT-R. O:E <1.0 across all risks. Longer-term data needed on gradient/durability, need for BVF/BVR. ht…